HVC
YARW

Healthcare Value Capital’s Yarrow Bioscience YARW Stock Holding History

Healthcare Value Capital’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$556K Sell
444
-56
-11% -$109K 1.1% 21
2021
Q2 		$1.58M Buy
500
+56
+13% +$222K 3.15% 14
2021
Q1 		$2.74M Sell
444
-112
-20% -$812K 6.1% 5
2020
Q4 		$3.16M Buy
556
+56
+11% +$352K 10.65% 3
2020
Q3 		$2.99M Buy
500
+28
+6% +$163K 9.85% 5
2020
Q2 		$2.94M Buy
472
+236
+100% +$1.6M 7.51% 4
2020
Q1 		$2.28M Buy
+236
New +$3.7M 3.83% 15

Other funds holding YARW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Healthcare Value Capital's YARW Position: Q3 2021 in Review

Healthcare Value Capital reduced its Yarrow Bioscience (YARW) stake by 11% in Q3 2021, selling an estimated $109K and leaving 444 shares worth $556K. The position accounts for 1.1% of the portfolio, ranked #21.

Healthcare Value Capital first reported a position in YARW in Q1 2020 and has held it in 7 quarters since. The position peaked at $3.16M in Q4 2020. 58 funds tracked by Wall St. Rank hold YARW as of Q3 2021.

  • Healthcare Value Capital held 444 shares of Yarrow Bioscience worth $556K as of Q3 2021.
  • Healthcare Value Capital sold 56 Yarrow Bioscience shares in Q3 2021, an estimated $109K.
  • Yarrow Bioscience made up 1.1% of Healthcare Value Capital's portfolio in Q3 2021, its #21 holding.
  • Healthcare Value Capital first reported a position in Yarrow Bioscience in Q1 2020 and has held it in 7 quarters since.
  • Healthcare Value Capital's Yarrow Bioscience position peaked at $3.16M in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.